Study reports potential target and compounds to slow the development of Alzheimer's disease

Researchers have discovered a potential biomarker for Alzheimer's disease diagnosis that may also serve as a therapeutic target. Examining cerebrospinal fluid samples from patients with cognitive impairment ranging from subjective impairment to a diagnosis of Alzheimer's disease, they found a shift in the profile of specialized liquid mediators from pro-resolving to pro-inflammatory.

from Latest Science News -- ScienceDaily https://ift.tt/lZ1McmU

Comments

Popular posts from this blog

Seismic study reveals key reason why Patagonia is rising as glaciers melt

New method to detect and visualize sperm cells recovered from forensic evidence